Cor Vasa 2017, 59(6):e540-e545 | DOI: 10.1016/j.crvasa.2016.12.011

Echocardiographic assessment of the left ventricular diastolic function in patients with non-alcoholic liver cirrhosis

Heba Farouka,*, Taha Al-Maimoonya, Abdo Nasra, Magdy El-Serafyb, Mohamed Abdel Ghanya
a Cardiovascular Medicine Department, Faculty of Medicine, Cairo University, Egypt
b Department of Tropical Medicine, Faculty of Medicine, Cairo University, Egypt

Aim: To assess the left ventricular diastolic function in patients with non-alcoholic liver cirrhosis and correlate the degree of diastolic dysfunction to the severity of liver impairment.

Methods: Thirty-five patients with non-alcoholic liver cirrhosis in addition to 16 age- and sex-matched healthy controls were studied. Severity of liver impairment was assessed using the Child-Pugh score. All participants were subjected to echocardiographic assessment using both the conventional and tissue Doppler echocardiography. The left ventricular filling pressure was derived from the transmitral and mitral annular velocities.

Results: Patients with non-alcoholic liver cirrhosis (mean age; 53 ± 6) had significantly higher heart rate compared with the controls (86 ± 6.5 bpm vs 72 ± 4, p = 0.04). Mild degree of left ventricular diastolic dysfunction was detected in 26% of patients using the transmitral diastolic parameters. Compared with controls, the calculated left ventricular filling pressure was statistically significantly higher in patients with non-alcoholic liver cirrhosis (10 ± 3 vs 9 ± 1, p = 0.002). Elevated left ventricular filling pressure was detected in only 4 patients. These patients had more advanced form of liver impairment, and were categorized as having normal left ventricular diastolic function based on the mitral inflow indexes.

Conclusions: One fourth of patients with non-alcoholic liver cirrhosis had mild degree of left ventricular diastolic dysfunction using the conventional echocardiographic parameters. Elevated resting left ventricular filling pressure was detected in 11% of patients. The use of multiple parameters to assess the left ventricular diastolic function in patients with liver cirrhosis could unmask cases with pseudonormal pattern.

Keywords: Cardiac complications; Left ventricular diastolic function; Left ventricular filling pressure; Liver cirrhosis; Liver transplantation; Mitral indexes

Received: June 24, 2016; Accepted: December 20, 2016; Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Farouk H, Al-Maimoony T, Nasr A, El-Serafy M, Ghany MA. Echocardiographic assessment of the left ventricular diastolic function in patients with non-alcoholic liver cirrhosis. Cor Vasa. 2017;59(6):e540-545. doi: 10.1016/j.crvasa.2016.12.011.
Download citation

References

  1. W.K. Al-Hamoudi, Cardiovascular changes in cirrhosis: pathogenesis and clinical implications, Saudi Journal of Gastroenterology 16 (2010) 145-153. Go to original source... Go to PubMed...
  2. E.M. Zardi, A. Abbate, D.M. Zardi, et al., Cirrhotic cardiomyopathy, Journal of the American College of Cardiology 10 (2010) 539-549. Go to original source... Go to PubMed...
  3. S.A. Alqahtani, T.R. Fouad, S.S. Lee, Cirrhotic cardiomyopathy, Seminars in Liver Disease 28 (2008) 59-69. Go to original source... Go to PubMed...
  4. H. Liu, D. Song, S.S. Lee, Cirrhotic cardiomyopathy, Gastroenterologie Clinique et Biologique 26 (2002) 842-847. Go to PubMed...
  5. S. Møller, J.H. Henriksen, Cardiovascular complications of cirrhosis, Gut 57 (2008) 268-278. Go to original source... Go to PubMed...
  6. R.N. Rabie, M. Cazzaniga, F. Salerno, F. Wong, The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt, American Journal of Gastroenterology 104 (2009) 2458-2466. Go to original source... Go to PubMed...
  7. M. Cazzaniga, F. Salerno, G. Pagnozzi, et al., Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt, Gut 56 (2007) 869-875. Go to original source... Go to PubMed...
  8. R.P. Myers, S.S. Lee, Cirrhotic cardiomyopathy and liver transplantation, Liver Transplantation 4 (Suppl. 1) (2000) S44-S52. Go to original source...
  9. M. Bernardi, S. Galandra, A. Colantoni, et al., Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors, Hepatology 27 (1998) 28-34. Go to original source... Go to PubMed...
  10. F. Wong, N. Girgrah, J. Graba, et al., The cardiac response to exercise in cirrhosis, Gut 49 (2001) 268-275. Go to original source... Go to PubMed...
  11. F. Wong, P. Liu, L. Lilly, et al., Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis, Clinical Science 97 (1999) 259-267. Go to original source...
  12. M. Pozzi, S. Carugo, G. Boari, et al., Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites, Hepatology 26 (1997) 1131-1137. Go to original source... Go to PubMed...
  13. G. Finucci, A. Desideri, D. Sacerdoti, et al., Left ventricular diastolic function in liver cirrhosis, Scandinavian Journal of Gastroenterology 31 (1996) 279-284. Go to original source...
  14. P.M. Mottram, T.H. Marwick, Assessment of diastolic function: what the general cardiologist needs to know, Heart 91 (2005) 681-695. Go to original source... Go to PubMed...
  15. R.M. Lang, M. Bierig, R.B. Devereux, et al., Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology, Journal of the American Society of Echocardiography 18 (2005) 1440-1463. Go to original source... Go to PubMed...
  16. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, et al., Recommendations for the evaluation of left ventricular diastolic function by echocardiography, European Journal of Echocardiography 10 (2009) 165-193. Go to original source... Go to PubMed...
  17. S.F. Nagueh, K.J. Middleton, H.A. Kopelen, et al., Doppler tissue Imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures, Journal of the American College of Cardiology 15 (1997) 1527-1533. Go to original source... Go to PubMed...
  18. W.J. Paulus, C. Tschöpe, J.E. Sanderson, et al., How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology, European Heart Journal 28 (2007) 2539-2550. Go to original source... Go to PubMed...
  19. L.G. Rudski, W.W. Lai, J. Afilalo, et al., Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography, Journal of the American Society of Echocardiography 23 (2010) 685-713. Go to original source... Go to PubMed...
  20. V. Valeriano, S. Funaro, R. Lionetti, et al., Modification of cardiac function in cirrhotic patients with and without ascites, American Journal of Gastroenterology 95 (2000) 3200-3205. Go to original source... Go to PubMed...
  21. V. Papastergiou, L. Skorda, P. Lisgos, et al., Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: is there a correlation between the grade of diastolic dysfunction and the grade of liver disease?, The Scientific World Journal 2012 (2012) 615057. Go to original source... Go to PubMed...
  22. K. Kazankov, P. Holland-Fischer, N.H. Andersen, et al., Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging, Liver International 31 (2011) 534-540. Go to original source... Go to PubMed...
  23. T.A. Abd-El-Aziz, M. Abdou, A. Fathy, M. Wafaie, Evaluation of cardiac function in patients with liver cirrhosis, Internal Medicine 49 (2010) 2547-2552. Go to original source... Go to PubMed...
  24. J.A. Solis-Herruzo, D. Moreno, A. Gonzalez, et al., Effect of intrathoracic pressure on plasma arginine vasopressin levels, Gastroenterology 101 (1991) 607-617. Go to original source... Go to PubMed...
  25. M. Torregrosa, S. Aguadé, L. Dos, et al., Cardiac alterations in cirrhosis: reversibility after liver transplantation, Journal of Hepatology 42 (2005) 68-74. Go to original source... Go to PubMed...
  26. G. Therapondos, A.D. Flapan, J.N. Plevris, P.C. Hayes, Cardiac morbidity and mortality related to orthotopic liver transplantation, Liver Transplantation 10 (2004) 1441-1453. Go to original source... Go to PubMed...
  27. C.L. Donovan, P.A. Marcovitz, J.D. Punch, et al., Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end stage liver disease prior to orthotopic liver transplantation, Transplantation 61 (1996) 1180-1188. Go to original source... Go to PubMed...
  28. S.A. Gaskari, H. Honar, S.S. Lee, Therapy insight: cirrhotic cardiomyopathy, Nature Clinical Practice. Gastroenterology and Hepatology 3 (2006) 329-337. Go to original source... Go to PubMed...
  29. A. Garg, W.F. Armstrong, Echocardiography in liver transplant candidates, Journal of the American College of Cardiology. Cardiovascular Imaging 6 (2013) 105-119. Go to original source... Go to PubMed...
  30. F. Schnell, E. Donal, R. Lorho, et al., Severe left-sided heart failure early after liver transplantation, Liver Transplantation 15 (2009) 1296-1305. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.